IL88197A0 - Sustained release delivery system for substituted dihydropyridine calcium channel blockers - Google Patents
Sustained release delivery system for substituted dihydropyridine calcium channel blockersInfo
- Publication number
- IL88197A0 IL88197A0 IL88197A IL8819788A IL88197A0 IL 88197 A0 IL88197 A0 IL 88197A0 IL 88197 A IL88197 A IL 88197A IL 8819788 A IL8819788 A IL 8819788A IL 88197 A0 IL88197 A0 IL 88197A0
- Authority
- IL
- Israel
- Prior art keywords
- delivery system
- sustained release
- calcium channel
- channel blockers
- release delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12544087A | 1987-11-25 | 1987-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL88197A0 true IL88197A0 (en) | 1989-06-30 |
Family
ID=22419737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL88197A IL88197A0 (en) | 1987-11-25 | 1988-10-28 | Sustained release delivery system for substituted dihydropyridine calcium channel blockers |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0317780B1 (xx) |
JP (1) | JPH02655A (xx) |
KR (1) | KR890007746A (xx) |
AT (1) | ATE76292T1 (xx) |
AU (1) | AU626187B2 (xx) |
DE (1) | DE3871343D1 (xx) |
DK (1) | DK656488A (xx) |
ES (1) | ES2037179T3 (xx) |
FI (1) | FI885454A (xx) |
GR (1) | GR3004988T3 (xx) |
IL (1) | IL88197A0 (xx) |
NO (1) | NO885246L (xx) |
NZ (1) | NZ226987A (xx) |
PT (1) | PT89055A (xx) |
ZA (1) | ZA888817B (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4117784A1 (de) * | 1991-05-31 | 1992-12-03 | Basf Ag | Herstellung von protein-polyalkylenglykolkonjugaten |
US5834496A (en) * | 1991-12-02 | 1998-11-10 | Sepracor, Inc. | Methods for treating hypertension using optically pure S(-) felodipine |
ATE151090T1 (de) * | 1993-06-29 | 1997-04-15 | Heylecina Societe Anonyme | Herstellung von aktivierten carbamaten von polyalkylenglycol und ihre verwendung |
IE80467B1 (en) * | 1995-07-03 | 1998-07-29 | Elan Corp Plc | Controlled release formulations for poorly soluble drugs |
EP0951279A1 (en) * | 1997-01-10 | 1999-10-27 | Abbott Laboratories | Tablet for the controlled release of active agents |
US6013280A (en) * | 1997-10-07 | 2000-01-11 | Fuisz Technologies Ltd. | Immediate release dosage forms containing microspheres |
SE9704401D0 (sv) * | 1997-11-28 | 1997-11-28 | Astra Ab | Matrix pellets for greasy, oily or sticky drug substances |
US7763769B2 (en) | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
DK1429126T3 (da) | 2002-12-09 | 2013-03-11 | Ishida Seisakusho | Kombinationsvægt |
DK1628663T3 (da) | 2003-05-15 | 2010-03-08 | Roskamp Res Llc | Fremgangsmåde til fremstilling af medikamenter til reduktion af amyloid-aflejring, amyloid-neurotoksicitet og mikrogliose |
CA2561733A1 (en) * | 2004-04-01 | 2005-10-13 | Cardiome Pharma Corp. | Pegylated ion channel modulating compounds |
US7705036B2 (en) | 2004-04-01 | 2010-04-27 | Cardiome Pharma Corp. | Deuterated aminocyclohexyl ether compounds and processes for preparing same |
EP1828099B1 (en) | 2004-11-18 | 2020-01-22 | Correvio International Sàrl | Synthetic process for aminocyclohexyl ether compounds |
CA2612375C (en) | 2005-06-15 | 2013-08-06 | Cardiome Pharma Corp. | Synthetic processes for the preparation of aminocyclohexyl ether compounds |
DK2214666T3 (da) | 2007-10-05 | 2014-01-27 | Alzheimer S Inst Of America Inc | Fremgangsmåde til reducering af amyloid-afsætning, amyloid-neurotoksicitet og mikrogliose med (-)-nilvadipin-enantiomer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA959759A (en) * | 1970-01-15 | 1974-12-24 | John J. Miskel | Method for absorption of drugs |
FR2518403B1 (fr) * | 1981-12-22 | 1987-01-02 | Dietlin Francois | Procede de preparation de formes pharmaceutiques presentant une resorption par voie digestive amelioree, et les formes pharmaceutiques ainsi obtenues |
IT1174779B (it) * | 1982-09-27 | 1987-07-01 | Sandoz Ag | L'impiego in terapeutica dei derivati della 1,4-di idropiridina |
NZ206600A (en) * | 1983-05-11 | 1987-01-23 | Alza Corp | Osmotic drug delivery device |
-
1988
- 1988-10-26 ES ES198888117844T patent/ES2037179T3/es not_active Expired - Lifetime
- 1988-10-26 DE DE8888117844T patent/DE3871343D1/de not_active Expired - Lifetime
- 1988-10-26 EP EP88117844A patent/EP0317780B1/en not_active Expired - Lifetime
- 1988-10-26 AT AT88117844T patent/ATE76292T1/de active
- 1988-10-28 IL IL88197A patent/IL88197A0/xx unknown
- 1988-11-17 NZ NZ226987A patent/NZ226987A/en unknown
- 1988-11-23 PT PT89055A patent/PT89055A/pt not_active Application Discontinuation
- 1988-11-23 AU AU25870/88A patent/AU626187B2/en not_active Expired - Fee Related
- 1988-11-24 FI FI885454A patent/FI885454A/fi not_active Application Discontinuation
- 1988-11-24 DK DK656488A patent/DK656488A/da not_active Application Discontinuation
- 1988-11-24 ZA ZA888817A patent/ZA888817B/xx unknown
- 1988-11-24 NO NO88885246A patent/NO885246L/no unknown
- 1988-11-24 JP JP63294806A patent/JPH02655A/ja active Pending
- 1988-11-25 KR KR1019880015572A patent/KR890007746A/ko not_active Application Discontinuation
-
1992
- 1992-06-19 GR GR920400263T patent/GR3004988T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR890007746A (ko) | 1989-07-05 |
NO885246L (no) | 1989-05-26 |
DK656488A (da) | 1989-05-26 |
EP0317780A1 (en) | 1989-05-31 |
NO885246D0 (no) | 1988-11-24 |
DE3871343D1 (de) | 1992-06-25 |
PT89055A (pt) | 1989-11-30 |
ES2037179T3 (es) | 1993-06-16 |
EP0317780B1 (en) | 1992-05-20 |
NZ226987A (en) | 1992-04-28 |
DK656488D0 (da) | 1988-11-24 |
AU2587088A (en) | 1989-05-25 |
FI885454A0 (fi) | 1988-11-24 |
ATE76292T1 (de) | 1992-06-15 |
FI885454A (fi) | 1989-05-26 |
GR3004988T3 (xx) | 1993-04-28 |
AU626187B2 (en) | 1992-07-23 |
JPH02655A (ja) | 1990-01-05 |
ZA888817B (en) | 1989-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL88197A0 (en) | Sustained release delivery system for substituted dihydropyridine calcium channel blockers | |
ES2061609T3 (es) | 2',3'-dideoxi-2'-fluoro-nucleosidos. | |
DE3888530D1 (de) | 3'-Azido-2',3'-dideoxynucleosid-5'-phosphonate. | |
ITMI913465A1 (it) | Procedimento per la depurazione dell'1, 1, 1-trifluoro-2-fluoroetano | |
GR870824B (en) | Process for the preparation of new 1,4 - dihydropyridines useful as antithrombotic drugs | |
GR3004863T3 (xx) | ||
TW245740B (xx) | ||
ES2038665T3 (es) | Procedimiento de sintesis de penems. | |
SE8700361D0 (sv) | Immunosuppressant agents | |
NZ229300A (en) | Substituted-2-ethenyl-3,4,5,6-tetrahydrothieno (4,3,2-cf)(3)benzazepine derivatives and pharmaceutical compositions | |
ATE90098T1 (de) | Cycloalkan(1,2-c:4,3-c'>dipyrazole. | |
NO904533D0 (no) | Fremgangsmaate for molekylvektsregulering av polydiklorfosfasener. | |
IT8721895A0 (it) | Policarbonati resistenti alla fiamma, contenenti nella catena polimerica unita' derivanti da composti tetrafenilici monoalogenati. | |
AU3644289A (en) | Novel derivatives, process for their preparation, intermediates and their use as medicaments | |
YU119788A (en) | Process for producing calcium 10-propyl-2,8-bis (1h-tetrazol-5-yl)-4h,6h-benzo (1,2-6,5,4-b') | |
IT217687Z2 (it) | Struttura di calzatura, particolarmente per l'arrampicata libera. | |
IT8921095A0 (it) | Composizione per l'aumento del guadagno di peso. | |
IT8719368A0 (it) | Composizione solida, resistente all'idrolisi, stabilizzante per i polimeri organici e procedimento per la sua preparazione. | |
GB8910205D0 (en) | 2,6-dimethyl-1,4-dihydrophyridine-3,5-dicarboxylic acid adamentyl esters | |
NO884264D0 (no) | 3'-azido-2',3'-dideoksyuridin-anti-retrovirus-blanding. | |
EP0537591A3 (en) | Process for the preparation of 1,2-bis-(2-nitrophenoxy)-ethane | |
IE880214L (en) | 3'-azido-2',3'-dideoxyuridine anti-retroviral compositions |